Thermo Fisher Scientific Total Current Assets decreased by 22.3% to $22.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.5%, from $23.38B to $22.32B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.26B | $24.72B | $20.11B | $18.78B | $18.10B | $19.30B | $25.23B | $20.21B | $20.00B | $23.09B | $24.59B | $23.64B | $25.48B | $23.78B | $22.14B | $23.38B | $24.58B | $22.30B | $28.71B | $22.32B |
| QoQ Change | — | +28.4% | -18.6% | -6.6% | -3.6% | +6.6% | +30.7% | -19.9% | -1.1% | +15.5% | +6.5% | -3.9% | +7.8% | -6.6% | -6.9% | +5.6% | +5.2% | -9.3% | +28.8% | -22.3% |
| YoY Change | — | — | — | — | -6.0% | -21.9% | +25.4% | +7.6% | +10.5% | +19.7% | -2.5% | +17.0% | +27.4% | +3.0% | -10.0% | -1.1% | -3.5% | -6.3% | +29.7% | -4.5% |